ABC transporters affect the detection of intracellular oxidants by fluorescent probes

References

• Ma Q. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther 2010; 125:376–393.
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000;28:1456–1462.
   PubMed Web of Science ®Google Scholar
• Hernandez-Garcia D, Wood CD, Castro-Obregon S, Covarrubias L. Reactive oxygen species: a radical role in development? Free Radic Biol Med 2010;49(2):130–43.
   PubMed Web of Science ®Google Scholar
• Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009;47:333–343.
   PubMed Web of Science ®Google Scholar
• Soh N. Recent advances in fluorescent probes for the detection of reactive oxygen species. Anal Bioanal Chem 2006;386: 532–543.
   PubMed Web of Science ®Google Scholar
• Dickinson BC, Srikun D, Chang CJ. Mitochondrial-targeted fluorescent probes for reactive oxygen species. Curr Opin Chem Biol 2009;14:50–56.
   PubMed Web of Science ®Google Scholar
• Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett 2006;580:2903–2909.
   PubMed Web of Science ®Google Scholar
• Raaijmakers MH. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia. Leukemia 2007;21:2094–2102.
   PubMed Web of Science ®Google Scholar
• Stavrovskaya AA, Stromskaya TP. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry (Mosc) 2008;73:592–604.
   PubMed Web of Science ®Google Scholar
• Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006;24:506–513.
   PubMed Web of Science ®Google Scholar
• Huls M, Russel FG, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 2009;328:3–9.
   PubMed Web of Science ®Google Scholar
• Abbott BL. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells. Hematol Oncol 2003;21:115–130.
   PubMed Web of Science ®Google Scholar
• Li X, Leder P. Identifying genes preferentially expressed in undifferentiated embryonic stem cells. BMC Cell Biol 2007; 8:37.
   PubMedGoogle Scholar
• Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7:1028–1034.
   PubMed Web of Science ®Google Scholar
• Apati A, Orban TI, Varga N, Nemeth A, Schamberger A, Krizsik V, . High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700–2709.
   PubMed Web of Science ®Google Scholar
• Ozvegy-Laczka C, Hegedus T, Varady G, Ujhelly O, Schuetz JD, Varadi A, . High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter. Mol Pharmacol 2004;65:1485–1495.
   PubMed Web of Science ®Google Scholar
• Soucek K, Pachernik J, Kubala L, Vondracek J, Hofmanova J, Kozubik A. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis. Leuk Res 2006;30: 607–623.
   PubMed Web of Science ®Google Scholar
• Pavelkova M, Kubala L. Luminol-, isoluminol- and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimulated with different activators. Luminescence 2004;19:37–42.
   PubMed Web of Science ®Google Scholar
• Rudolph TK, Rudolph V, Edreira MM, Cole MP, Bonacci G, Schopfer FJ, . Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2010;30:938–945.
   PubMed Web of Science ®Google Scholar
• Vesela I, Kotasova H, Jankovska S, Prochazkova J, Pachernik J. Leukaemia inhibitory factor inhibits cardiomyogenesis of mouse embryonic stem cells via STAT3 activation. Folia Biol (Praha) 2010;56:165–172.
   PubMed Web of Science ®Google Scholar
• Prochazkova J, Stixova L, Soucek K, Hofmanova J, Kozubik A. Monocytic differentiation of leukemic HL-60 cells induced by co-treatment with TNF-alpha and MK886 requires activation of pro-apoptotic machinery. Eur J Haematol 2009;83:35–47.
   PubMed Web of Science ®Google Scholar
• Hollo Z, Homolya L, Davis CW, Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1994;1191:384–388.
   PubMed Web of Science ®Google Scholar
• Robey RW, Honjo Y, van de Laar A, Miyake K, Regis JT, Litman T, Bates SE. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta 2001;1512:171–182.
   PubMed Web of Science ®Google Scholar
• Ambrozova G, Pekarova M, Lojek A. Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages. Eur J Nutr 2010;49: 133–139.
   PubMed Web of Science ®Google Scholar
• LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5:227–231.
   PubMed Web of Science ®Google Scholar
• Bucana CD, Giavazzi R, Nayar R, O'Brian CA, Seid C, Earnest LE, Fan D. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Exp Cell Res 1990;190: 69–75.
   PubMed Web of Science ®Google Scholar
• Masereeuw R, Moons MM, Russel FG. Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur J Pharmacol 1997;321:315–323.
   PubMed Web of Science ®Google Scholar
• van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 2000;11:207–214.
   PubMed Web of Science ®Google Scholar
• Nare B, Prichard RK, Georges E. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol Pharmacol 1994;45:1145–1152.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Fukura Y, Shinohara Y, Baba Y. Analysis of mitochondrial membrane potential in the cells by microchip flow cytometry. Electrophoresis 2005;26:3025–3031.
   PubMed Web of Science ®Google Scholar
• Hasmann M, Valet GK, Tapiero H, Trevorrow K, Lampidis T. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry. Biochem Pharmacol 1989;38:305–312.
   PubMed Web of Science ®Google Scholar
• Hendrich AB, Wesolowska O, Pola A, Motohashi N, Molnar J, Michalak K. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. Mol Membr Biol 2003;20:53–60.
   PubMed Web of Science ®Google Scholar
• Vasconcelos FC, Cavalcanti GB, Jr, Silva KL, de Meis E, Kwee JK, Rumjanek VM, Maia RC. Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice. Leuk Res 2007;31: 445–454.
   PubMed Web of Science ®Google Scholar
• Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40–45.
   PubMed Web of Science ®Google Scholar
• Kuhnel JM, Perrot JY, Faussat AM, Marie JP, Schwaller MA. Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia 1997;11: 1147–1155.
   PubMed Web of Science ®Google Scholar
• Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, . Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002;158:507–517.
   PubMed Web of Science ®Google Scholar
• Rajagopal A, Pant AC, Simon SM, Chen Y. In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1. Cancer Res 2002;62:391–396.
   PubMed Web of Science ®Google Scholar
• Rajagopal A, Simon SM. Subcellular localization and activity of multidrug resistance proteins. Mol Biol Cell 2003;14: 3389–3399.
   PubMed Web of Science ®Google Scholar
• Olson DP, Taylor BJ, Ivy SP. Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate. Cytometry 2001;46:105–113.
   PubMedGoogle Scholar
• Krejcova D, Prochazkova J, Kubala L, Pachernik J. Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha. Gen Physiol Biophys 2009;28:294–301.
   PubMed Web of Science ®Google Scholar
• Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998;98:1153–1157.
   PubMed Web of Science ®Google Scholar
• Cirino M, Motz C, Maw J, Ford-Hutchinson AW, Yano M. BQ-153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin-1. J Pharm Pharmacol 1992;44:782–785.
   PubMed Web of Science ®Google Scholar
• Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995;208:345–352.
   PubMed Web of Science ®Google Scholar
• Cui CB, Kakeya H, Okada G, Onose R, Osada H. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties. J Antibiot (Tokyo) 1996;49:527–533.
   PubMed Web of Science ®Google Scholar
• Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2). J Med Chem 2005;48: 7275–7281.
   PubMed Web of Science ®Google Scholar
• Solazzo M, Fantappie O, D'Amico M, Sassoli C, Tani A, Cipriani G, . Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res 2009;69: 7235–7242.
   PubMed Web of Science ®Google Scholar
• Jeong JM, Choi CH, Kang SK, Lee IH, Lee JY, Jung H. Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J Pharm Pharm Sci 2007;10:537–546.
   PubMed Web of Science ®Google Scholar
• Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, . Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells. Mol Cancer Ther 2002;1:185–195.
   PubMed Web of Science ®Google Scholar
• Bustamante J, Caldas Lopes E, Garcia M, Di Libero E, Alvarez E, Hajos SE. Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia. Toxicol Appl Pharmacol 2004;199:44–51.
   PubMed Web of Science ®Google Scholar
• Sun W, Wang W, Kim J, Keng P, Yang S, Zhang H, . Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol 2008;614:179–186.
   PubMed Web of Science ®Google Scholar